Tawny Hung M.D., F.R.C.P.C.

Dr. Hung received her MD and Anatomic Pathology training at the University of British Columbia in Vancouver, BC, and Dermatopathology Training at the University of California Los Angeles (UCLA). She joined Dynalifedx Laboratories in 2013 and has been an active teacher within the departments of pathology and dermatology at the University of Alberta. Dr. Hung has published many articles in the literature in dermatopathology, including work on atypical spitz tumors and atypical cellular blue nevi. She is a peer reviewer for the American Journal of Dermatopathology and Australasian Journal of Dermatology. Her mission in the clinical realm is toward more efficient and cost-effective laboratory processing integrated with an expert consultative diagnostic service.


Charlene Hunter

Dr. Charlene Hunter is a staff pathologist and dermatopathologist at Calgary lab services in Calgary, AB. She holds a clinical Assistant Professor position in the Department of Pathology & Laboratory medicine at the Cumming School of Medicine, University of Calgary. She completed a fellowship in dermatopathology at the University of Alberta in 2009 and received her International Board certification in dermatopathology in 2010. She currently leads a group of four dermatopathologists in the department as Specialty group leader. In addition to this role she is a member of the residency training committee in dermatology.


Doha Itani

Dr. Doha Itani is an Assistant Professor with the Department of Pathology and Laboratory Medicine, University of Calgary.

Dr. Itani joined the University of Calgary, Department of Pathology and Laboratory Medicine in 2013. She obtained her doctorate in medicine from the American University of Beirut. Her training is in Anatomic and Clinical Pathology. She completed her residency and Molecular Genetics Pathology fellowship training at Vanderbilt University Medical Center and her Hematology Pathology fellowship at Johns Hopkins Hospital. Dr. Itani has special interest in the discipline of Bone and Soft Tissue and the related molecular and genetic alterations.